CMN 41.63 Cantel Medical $CMN Hit a 52 week high o
Post# of 78
Posted On: 11/14/2014 11:20:46 AM
CMN 41.63 Cantel Medical $CMN Hit a 52 week high of 42.21 Closing the day 09:41 at 41.63 -0.66 -1.56% With a day low of 41.47 and a total volume of 2,165.
CMN Recent Posts: http://investorshangout.com/Cantel-Medical-Corp-CMN-50561/
CMN Cantel Medical Recent Headline News
Uptrend Call Working As Cantel Medical Stock Rises 16.3% (CMN)
Comtex SmarTrend(R) - Wed Nov 12, 11:10AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 1 month, Cantel Medical has returned 16.29% as of today's recent price of $42.30.
CMN: 41.89 (-0.40)
Worried About a Market Crash? These 3 Stocks Soared During the Great Recession
Todd Campbell, The Motley Fool - Motley Fool - Tue Nov 11, 6:38AM CST
The 7.2% drop in the S&P 500 between mid-September and mid-October was an attention-getting fall that should serve as a wake-up call to investors who may have grown complacent over the past five years, but by historical standards the decline was...
CTRX: 48.40 (+0.17), EBS: 24.19 (-0.13), CMN: 41.89 (-0.40)
Cantel Medical To Present At The Stifel 2014 Healthcare Conference
PR Newswire - Mon Nov 10, 10:07AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Stifel 2014 Healthcare Conference at The New York Palace Hotel in New York, New York. The formal presentation is scheduled for Tuesday, November 18, 2014 at 10:20 AM Eastern Time. In addition, Mr. Krakauer and Jorgen B. Hansen, Executive Vice President & COO, will be available for separate one-on-one meetings during the day.
CMN: 41.89 (-0.40)
Cantel Medical's board to pay higher semiannual dividend of USD0.05 per outstanding share
M2 - Mon Nov 10, 7:46AM CST
The board of directors of Cantel Medical (NYSE:CMN), a medical device company, on Friday declared a semiannual dividend of USD0.05 per outstanding share of the company's common stock.
CMN: 41.89 (-0.40)
Cantel Medical declares $0.05 dividend
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 7:45AM CST
CMN: 41.89 (-0.40)
Cantel Medical Board Of Directors Authorizes Increase In Semiannual Dividend
PR Newswire - Fri Nov 07, 7:00AM CST
CANTEL MEDICAL CORP. (NYSE:CMN) announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.045 to $0.05 per outstanding share of the Company's Common Stock. The dividend is payable on January 30, 2015 to shareholders of record at the close of business on January 16, 2015.
CMN: 41.89 (-0.40)
Cantel Medical Up 15.5% Since SmarTrend Uptrend Call (CMN)
Comtex SmarTrend(R) - Wed Nov 05, 9:50AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 4 weeks, Cantel Medical has returned 15.55% as of today's recent price of $42.03.
CMN: 41.89 (-0.40)
Cantel Medical buys International Medical Service S.r.l for EUR19.6m cash
M2 - Wed Nov 05, 6:26AM CST
Infection prevention company Cantel Medical (NYSE:CMN) reported on Tuesday that it has completed the acquisition of International Medical Service S.r.l (IMS) for a cash purchase price of EUR19.6m.
CMN: 41.89 (-0.40)
Cantel Medical Acquires International Medical Service S.r.l.
PR Newswire - Tue Nov 04, 7:00AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) today announced that it acquired International Medical Service S.r.l, or IMS, for a purchase price of EUR 19.6 million in cash consideration. Located in Pomezia, Italy, IMS is a leading manufacturer of high-level disinfectant chemistries used in automated endoscope reprocessors (AERs) as well as other infection prevention and control chemistries used in healthcare and dental markets. In addition, IMS is a manufacturer of high-quality AERs and holds leading share in the Italian AER market. IMS has an employee base of approximately 60 individuals including a complete sales and service team for the Italian market as well as a robust engineering group.
CMN: 41.89 (-0.40)
Cantel Medical Is Not Overvalued At This Price
Jonathan Weber - at Seeking Alpha - Wed Oct 29, 9:20AM CDT
CMN: 41.89 (-0.40)
13.3% Return Seen to Date on SmarTrend Cantel Medical Call (CMN)
Comtex SmarTrend(R) - Wed Oct 29, 9:19AM CDT
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 3 weeks, Cantel Medical has returned 13.35% as of today's recent price of $41.23.
CMN: 41.89 (-0.40)
New York Surgical Mask Manufacturer Responds to PPE Recommendations, Healthcare Worker Concerns
PR Newswire - Tue Oct 28, 7:30AM CDT
The CDC recently revised their Personal Protective Equipment (PPE) recommendations for healthcare workers caring for Ebola Virus Disease (EVD) patients to include the use of N95 or PAPR respirators and full coverage of all exposed skin. Emory Healthcare, a targeted treatment facility for EVD patients, also released their Healthcare Ebola Preparedness Protocols draft document http://www.emoryhealthcare.org/ebola-protocol...tocols.pdf. While the CDC recommendations are specific only to direct patient care of diagnosed EVD patients and exclude the use of medical face masks in this specific scenario, Emory's recommendations involve a broader set of EVD scenarios (Appendix 5; a "PPE Guidance Matrix for EVD"
, and specifically recommends the use of face masks in every situation, except during the care of a diagnosed, symptomatic EVD patient.
CMN: 41.89 (-0.40)
Cantel Medical Named to the Forbes 2014 List of the "100 Best Small Companies in America"
PR Newswire - Thu Oct 23, 7:30AM CDT
CANTEL MEDICAL CORP. (NYSE:CMN) announced today that for the third consecutive year, it was named to the Forbes list of the "100 Best Small Companies in America." The Company was ranked number 79 on the Forbes 2014 list.
CMN: 41.89 (-0.40)
InsiderInsights.com Daily Round Up 10/20/14: REGN, OPK, AGCO, HSON
InsiderInsights - at Seeking Alpha - Tue Oct 21, 8:35AM CDT
ZF: 15.15 (-0.01), AGCO: 44.12 (+0.03), HSON: 3.33 (-0.08), NNVC: 3.36 (-0.11), CMN: 41.89 (-0.40), GOOG: 544.59 (-0.79), HPQ: 36.84 (+0.48), RPXC: 13.98 (+0.08), ZTR: 13.85 (unch), UNFI: 74.03 (+0.03), OPK: 8.28 (-0.06), ARDC: 16.71 (-0.01), GOOGL: 554.73 (-1.71), GIS: 50.98 (-0.02), GWB: 21.55 (+0.23), REGN: 398.88 (-3.75), RFP: 18.75 (+0.13), URI: 114.41 (+0.86)
Insider Buys And Sells: Energy Transfer Equity, Vornado Realty Trust
Asif Suria - at Seeking Alpha - Mon Oct 20, 6:07AM CDT
Welcome to edition 226 of Insider Weekends. Insider buying increased significantly last week with insiders buying $165.25 million of stock compared to $51.96 million in the week prior. Selling also increased with insiders selling $653.17 million of...
DVN: 63.10 (-0.18), AYI: 139.05 (+1.02), VNO: 108.78 (+0.63), OPK: 8.28 (-0.06), DEI: 27.86 (-0.02), AGCO: 44.12 (+0.03), HBI: 110.52 (+1.21), ETE: 60.62 (-0.30), CSX: 36.79 (+0.16), CMN: 41.89 (-0.40)
InsiderInsights.com Daily Round Up 10/16/14: AGCO Corp., Google, Facebook And Ralph Lauren
InsiderInsights - at Seeking Alpha - Fri Oct 17, 6:39AM CDT
GWRE: 51.36 (-0.41), MGU: 25.59 (-0.05), FB: 74.64 (+0.39), HYB: 9.43 (-0.02), BYFC: 1.56 (+0.06), AGCO: 44.12 (+0.03), RL: 173.71 (+0.54), CMN: 41.89 (-0.40), GAM: 35.30 (+0.14), GOOG: 544.59 (-0.79), VEEV: 27.70 (-0.68), ARMF: 20.20 (-0.06), AYI: 139.05 (+1.02), DNP: 10.49 (+0.01), PF: 33.74 (+0.11)
Not Just Another Ebola Stock
Bill Gunderson - Seeking Alpha - Thu Oct 16, 7:43AM CDT
Cantel Medical Corp. (NYSE: CMN ) is a global provider of infection prevention and control products and services to the healthcare market. The company is based in Little Falls, New Jersey. Cantel Medical's business focuses on three product segments: ...
CMN: 41.89 (-0.40)
Lakeland Industries: Storm Warnings Ahead For Those Sailing On This LAKE
Looking For Diogenes - at Seeking Alpha - Wed Oct 15, 5:41AM CDT
STE: 64.17 (-0.76), APT: 2.94 (+0.07), LAKE: 11.59 (+0.20), CMN: 41.89 (-0.40)
Today's Strong And Under The Radar Stock: Cantel Medical (CMN)
at The Street - Wed Oct 08, 1:24PM CDT
Trade-Ideas LLC identified Cantel Medical (CMN) as a strong and under the radar candidate
CMN: 41.89 (-0.40)
Global Laboratory Filtration Market Outlook 2019: Pall Corporation and Merck Millipore Dominates the $2.53 Billion Industry
M2 - Mon Oct 06, 9:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gb4k5m/laboratory) has announced the addition of the "Laboratory Filtration Market by Technology, Product, Accessories & by End-User - Global Forecasts to 2019" report to their offering. The global laboratory filtration market is expected to grow at a strong CAGR during the forecast period of 2014-2019 and is estimated to be worth $2,532.6 million by 2019 The market is mainly driven by the increasing research activities in the pharmaceutical and biotechnology segments, and growing demand for biotech molecules for therapeutic and diagnostic applications and increasing purity requirements in end-user markets. However, technological developments cutting down the use of the membrane filtration technology may hamper the growth of the market to a certain extent. During the forecast period the microfiltration segment will continue to dominate the laboratory filtration market. Microfiltration segment is growing primarily due to increasing use of microfiltration membranes as prefilters to ultrafiltration and reverse osmosis processes. Furthermore, growing demand of filtration technologies in pharmaceutical and biopharmaceutical industries is also expected to drive the growth of the laboratory filtration market. By 2019, North America will be the largest share to the global laboratory filtration market, followed by Europe, Asia-Pacific, and RoW. Developed markets like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market. The Asia Pacific region is expected to have the fastest market growth during the forecast period, largely driven by the increasing research funding form government and private investors and growing number of research laboratories. Pall Corporation (U.S.) and Merck Millipore (U.S.) are the leading players, together accounting for around 35% to 40% share in the global laboratory filtration market in 2013. Pall Corporation has a diversified product portfolio, which includes a wide range of filtration products including filter capsules, membrane filters, filter funnels, filter holders, syringe filters, and laboratory water purification systems. The company has an extensive experience and expertise in filtration technology. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Laboratory Filtration Market, By Technology 8 Global Laboratory Filtration Equipment Market, By Type 9 Global Lab Filtration Accessories Market, By Type 10 Global Laboratory Filtration Market, By End User 11 Laboratory Filtration Market, By Geography 12 Competitive Landscape 13 Company Profiles - 3M Company - Cantel Medical Corp. - General Electric Company - Merck Millipore - Pall Corporation - Sartorius Group - Sigma-Aldrich Corporation - Sterlitech Corporation - Thermo Fisher Scientific, Inc. - Veolia Water Technologies Corporation For more information visit http://www.researchandmarkets.com/research/gb4k5m/laboratory
MMM: 158.76 (+0.41), GE: 26.49 (+0.07), PLL: 93.57 (-0.21), SIAL: 135.56 (+0.03), MRK: 58.87 (-0.67), CMN: 41.89 (-0.40)
CMN Recent Posts: http://investorshangout.com/Cantel-Medical-Corp-CMN-50561/
CMN Cantel Medical Recent Headline News
Uptrend Call Working As Cantel Medical Stock Rises 16.3% (CMN)
Comtex SmarTrend(R) - Wed Nov 12, 11:10AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 1 month, Cantel Medical has returned 16.29% as of today's recent price of $42.30.
CMN: 41.89 (-0.40)
Worried About a Market Crash? These 3 Stocks Soared During the Great Recession
Todd Campbell, The Motley Fool - Motley Fool - Tue Nov 11, 6:38AM CST
The 7.2% drop in the S&P 500 between mid-September and mid-October was an attention-getting fall that should serve as a wake-up call to investors who may have grown complacent over the past five years, but by historical standards the decline was...
CTRX: 48.40 (+0.17), EBS: 24.19 (-0.13), CMN: 41.89 (-0.40)
Cantel Medical To Present At The Stifel 2014 Healthcare Conference
PR Newswire - Mon Nov 10, 10:07AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, President & CEO, will be presenting at the Stifel 2014 Healthcare Conference at The New York Palace Hotel in New York, New York. The formal presentation is scheduled for Tuesday, November 18, 2014 at 10:20 AM Eastern Time. In addition, Mr. Krakauer and Jorgen B. Hansen, Executive Vice President & COO, will be available for separate one-on-one meetings during the day.
CMN: 41.89 (-0.40)
Cantel Medical's board to pay higher semiannual dividend of USD0.05 per outstanding share
M2 - Mon Nov 10, 7:46AM CST
The board of directors of Cantel Medical (NYSE:CMN), a medical device company, on Friday declared a semiannual dividend of USD0.05 per outstanding share of the company's common stock.
CMN: 41.89 (-0.40)
Cantel Medical declares $0.05 dividend
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 7:45AM CST
CMN: 41.89 (-0.40)
Cantel Medical Board Of Directors Authorizes Increase In Semiannual Dividend
PR Newswire - Fri Nov 07, 7:00AM CST
CANTEL MEDICAL CORP. (NYSE:CMN) announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.045 to $0.05 per outstanding share of the Company's Common Stock. The dividend is payable on January 30, 2015 to shareholders of record at the close of business on January 16, 2015.
CMN: 41.89 (-0.40)
Cantel Medical Up 15.5% Since SmarTrend Uptrend Call (CMN)
Comtex SmarTrend(R) - Wed Nov 05, 9:50AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 4 weeks, Cantel Medical has returned 15.55% as of today's recent price of $42.03.
CMN: 41.89 (-0.40)
Cantel Medical buys International Medical Service S.r.l for EUR19.6m cash
M2 - Wed Nov 05, 6:26AM CST
Infection prevention company Cantel Medical (NYSE:CMN) reported on Tuesday that it has completed the acquisition of International Medical Service S.r.l (IMS) for a cash purchase price of EUR19.6m.
CMN: 41.89 (-0.40)
Cantel Medical Acquires International Medical Service S.r.l.
PR Newswire - Tue Nov 04, 7:00AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) today announced that it acquired International Medical Service S.r.l, or IMS, for a purchase price of EUR 19.6 million in cash consideration. Located in Pomezia, Italy, IMS is a leading manufacturer of high-level disinfectant chemistries used in automated endoscope reprocessors (AERs) as well as other infection prevention and control chemistries used in healthcare and dental markets. In addition, IMS is a manufacturer of high-quality AERs and holds leading share in the Italian AER market. IMS has an employee base of approximately 60 individuals including a complete sales and service team for the Italian market as well as a robust engineering group.
CMN: 41.89 (-0.40)
Cantel Medical Is Not Overvalued At This Price
Jonathan Weber - at Seeking Alpha - Wed Oct 29, 9:20AM CDT
CMN: 41.89 (-0.40)
13.3% Return Seen to Date on SmarTrend Cantel Medical Call (CMN)
Comtex SmarTrend(R) - Wed Oct 29, 9:19AM CDT
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 3 weeks, Cantel Medical has returned 13.35% as of today's recent price of $41.23.
CMN: 41.89 (-0.40)
New York Surgical Mask Manufacturer Responds to PPE Recommendations, Healthcare Worker Concerns
PR Newswire - Tue Oct 28, 7:30AM CDT
The CDC recently revised their Personal Protective Equipment (PPE) recommendations for healthcare workers caring for Ebola Virus Disease (EVD) patients to include the use of N95 or PAPR respirators and full coverage of all exposed skin. Emory Healthcare, a targeted treatment facility for EVD patients, also released their Healthcare Ebola Preparedness Protocols draft document http://www.emoryhealthcare.org/ebola-protocol...tocols.pdf. While the CDC recommendations are specific only to direct patient care of diagnosed EVD patients and exclude the use of medical face masks in this specific scenario, Emory's recommendations involve a broader set of EVD scenarios (Appendix 5; a "PPE Guidance Matrix for EVD"
, and specifically recommends the use of face masks in every situation, except during the care of a diagnosed, symptomatic EVD patient. CMN: 41.89 (-0.40)
Cantel Medical Named to the Forbes 2014 List of the "100 Best Small Companies in America"
PR Newswire - Thu Oct 23, 7:30AM CDT
CANTEL MEDICAL CORP. (NYSE:CMN) announced today that for the third consecutive year, it was named to the Forbes list of the "100 Best Small Companies in America." The Company was ranked number 79 on the Forbes 2014 list.
CMN: 41.89 (-0.40)
InsiderInsights.com Daily Round Up 10/20/14: REGN, OPK, AGCO, HSON
InsiderInsights - at Seeking Alpha - Tue Oct 21, 8:35AM CDT
ZF: 15.15 (-0.01), AGCO: 44.12 (+0.03), HSON: 3.33 (-0.08), NNVC: 3.36 (-0.11), CMN: 41.89 (-0.40), GOOG: 544.59 (-0.79), HPQ: 36.84 (+0.48), RPXC: 13.98 (+0.08), ZTR: 13.85 (unch), UNFI: 74.03 (+0.03), OPK: 8.28 (-0.06), ARDC: 16.71 (-0.01), GOOGL: 554.73 (-1.71), GIS: 50.98 (-0.02), GWB: 21.55 (+0.23), REGN: 398.88 (-3.75), RFP: 18.75 (+0.13), URI: 114.41 (+0.86)
Insider Buys And Sells: Energy Transfer Equity, Vornado Realty Trust
Asif Suria - at Seeking Alpha - Mon Oct 20, 6:07AM CDT
Welcome to edition 226 of Insider Weekends. Insider buying increased significantly last week with insiders buying $165.25 million of stock compared to $51.96 million in the week prior. Selling also increased with insiders selling $653.17 million of...
DVN: 63.10 (-0.18), AYI: 139.05 (+1.02), VNO: 108.78 (+0.63), OPK: 8.28 (-0.06), DEI: 27.86 (-0.02), AGCO: 44.12 (+0.03), HBI: 110.52 (+1.21), ETE: 60.62 (-0.30), CSX: 36.79 (+0.16), CMN: 41.89 (-0.40)
InsiderInsights.com Daily Round Up 10/16/14: AGCO Corp., Google, Facebook And Ralph Lauren
InsiderInsights - at Seeking Alpha - Fri Oct 17, 6:39AM CDT
GWRE: 51.36 (-0.41), MGU: 25.59 (-0.05), FB: 74.64 (+0.39), HYB: 9.43 (-0.02), BYFC: 1.56 (+0.06), AGCO: 44.12 (+0.03), RL: 173.71 (+0.54), CMN: 41.89 (-0.40), GAM: 35.30 (+0.14), GOOG: 544.59 (-0.79), VEEV: 27.70 (-0.68), ARMF: 20.20 (-0.06), AYI: 139.05 (+1.02), DNP: 10.49 (+0.01), PF: 33.74 (+0.11)
Not Just Another Ebola Stock
Bill Gunderson - Seeking Alpha - Thu Oct 16, 7:43AM CDT
Cantel Medical Corp. (NYSE: CMN ) is a global provider of infection prevention and control products and services to the healthcare market. The company is based in Little Falls, New Jersey. Cantel Medical's business focuses on three product segments: ...
CMN: 41.89 (-0.40)
Lakeland Industries: Storm Warnings Ahead For Those Sailing On This LAKE
Looking For Diogenes - at Seeking Alpha - Wed Oct 15, 5:41AM CDT
STE: 64.17 (-0.76), APT: 2.94 (+0.07), LAKE: 11.59 (+0.20), CMN: 41.89 (-0.40)
Today's Strong And Under The Radar Stock: Cantel Medical (CMN)
at The Street - Wed Oct 08, 1:24PM CDT
Trade-Ideas LLC identified Cantel Medical (CMN) as a strong and under the radar candidate
CMN: 41.89 (-0.40)
Global Laboratory Filtration Market Outlook 2019: Pall Corporation and Merck Millipore Dominates the $2.53 Billion Industry
M2 - Mon Oct 06, 9:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gb4k5m/laboratory) has announced the addition of the "Laboratory Filtration Market by Technology, Product, Accessories & by End-User - Global Forecasts to 2019" report to their offering. The global laboratory filtration market is expected to grow at a strong CAGR during the forecast period of 2014-2019 and is estimated to be worth $2,532.6 million by 2019 The market is mainly driven by the increasing research activities in the pharmaceutical and biotechnology segments, and growing demand for biotech molecules for therapeutic and diagnostic applications and increasing purity requirements in end-user markets. However, technological developments cutting down the use of the membrane filtration technology may hamper the growth of the market to a certain extent. During the forecast period the microfiltration segment will continue to dominate the laboratory filtration market. Microfiltration segment is growing primarily due to increasing use of microfiltration membranes as prefilters to ultrafiltration and reverse osmosis processes. Furthermore, growing demand of filtration technologies in pharmaceutical and biopharmaceutical industries is also expected to drive the growth of the laboratory filtration market. By 2019, North America will be the largest share to the global laboratory filtration market, followed by Europe, Asia-Pacific, and RoW. Developed markets like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market. The Asia Pacific region is expected to have the fastest market growth during the forecast period, largely driven by the increasing research funding form government and private investors and growing number of research laboratories. Pall Corporation (U.S.) and Merck Millipore (U.S.) are the leading players, together accounting for around 35% to 40% share in the global laboratory filtration market in 2013. Pall Corporation has a diversified product portfolio, which includes a wide range of filtration products including filter capsules, membrane filters, filter funnels, filter holders, syringe filters, and laboratory water purification systems. The company has an extensive experience and expertise in filtration technology. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Laboratory Filtration Market, By Technology 8 Global Laboratory Filtration Equipment Market, By Type 9 Global Lab Filtration Accessories Market, By Type 10 Global Laboratory Filtration Market, By End User 11 Laboratory Filtration Market, By Geography 12 Competitive Landscape 13 Company Profiles - 3M Company - Cantel Medical Corp. - General Electric Company - Merck Millipore - Pall Corporation - Sartorius Group - Sigma-Aldrich Corporation - Sterlitech Corporation - Thermo Fisher Scientific, Inc. - Veolia Water Technologies Corporation For more information visit http://www.researchandmarkets.com/research/gb4k5m/laboratory
MMM: 158.76 (+0.41), GE: 26.49 (+0.07), PLL: 93.57 (-0.21), SIAL: 135.56 (+0.03), MRK: 58.87 (-0.67), CMN: 41.89 (-0.40)
(0)
(0)